Johnson & Johnson's (J&J) decision to fight the billions lawsuits against it in court is a strategy to deter future claims it thinks are "without merit", according to lawyers battling the pharma giant. J&J faces paying more than 100,000 in compensation, but legal experts said the company has won its fair share of cases too and could emulate Merck by eventually moving to less costly settlements.
Johnson & Johnson's (J&J) decision to fight the more than 100,000 lawsuits against it in court is a strategy to deter future claims it thinks are "without merit", according to lawyers battling the pharma giant. J&J faces paying billions in compensation, but legal experts said the company has won its fair share of cases too and could emulate Merck by eventually moving to less costly settlements.